Evidence map›Paper›PMID 40693062›Full record

ArticleCureus2025

Renal Involvement in Primary Sjögren's Syndrome: A Multi-centric Study From North India.

Scienthia Sanjeevani, Pallavi Prasad, Sourabh Sharma, Sahil Bagai, Dinesh Khullar

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Scienthia SanjeevaniNephrology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Pallavi PrasadNephrology, Vardhman Mahavir Medical College (VMMC) and Safdarjung Hospital, New Delhi, IND.
Sourabh SharmaNephrology, Vardhman Mahavir Medical College (VMMC) and Safdarjung Hospital, New Delhi, IND.
Sahil BagaiNephrology, Max Super Speciality Hospital Saket New Delhi, New Delhi, IND.
Dinesh KhullarNephrology, Max Super Speciality Hospital Saket New Delhi, New Delhi, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Renal involvement in primary Sjögren's syndrome is often underdiagnosed and overlooked. There is a lack of substantial data on the renal manifestations and outcomes in these patients. This study aims to stress the importance of thorough evaluation of renal dysfunction in individuals with Sjögren's syndrome to improve their overall health and quality of life. Methods This multicentric, retrospective study analyzed patients with renal involvement in Primary Sjögren's syndrome from 2013 to 2021. Clinical profiles of those affected by primary Sjögren's syndrome and renal involvement were examined. Patients were enrolled based on specific inclusion criteria, and relevant biochemical tests and kidney biopsy results were reviewed. One-year follow-up data was also included. Results A total of 38 patients were studied, with a strong female predominance (N=36, 94.7%) and a mean age of 41.4 ± 14.08 years. Reduced estimated glomerular filteration rate (eGFR; <60 ml/min/1.73 m²) was found in 24 patients (63%), while seven (18.4%) were diagnosed with nephrotic syndrome, another seven (18.4%) had sub-nephrotic range proteinuria, and four (10.5%) presented with microscopic hematuria. Two patients (5.2%) were already on maintenance hemodialysis when diagnosed with Sjögren's syndrome, and one patient was identified post-kidney transplant. Renal biopsies revealed various pathological findings, with chronic tubulointerstitial nephritis being the most common (N=4/11, 36.3%). Immunosuppressive therapy was given to 20 patients (56%), primarily steroids alone (N=8, 21%), while others received conservative management and supportive care. Conclusion Chronic tubulointerstitial nephritis is the most frequent form of renal involvement in Primary Sjögren's syndrome, with most cases diagnosed at advanced stages of kidney disease. This study underscores the importance of early and comprehensive renal evaluations in patients with Sjögren's syndrome, as early detection and timely treatment may help prevent progression to chronic kidney disease. Learning points Screening for renal involvement in primary Sjögren's syndrome (pSS) should include urinalysis, serum creatinine levels, and kidney biopsy when appropriate. A kidney biopsy showing characteristic findings, such as tubulointerstitial nephritis (TIN), should be considered an additional supportive criterion for the classification of pSS, as it can influence both treatment decisions and renal outcomes.

Indexed as

chronic tubulointerstitial diseaseconnective tissue disorderkidney biopsyrenal tubular acidosis (rta)sjogren's disease

Identifiers

PMID40693062
PMCPMC12278995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.